Description
Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
| Product Name: | Semaglutide |
| Synonyms: | Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Ozempic, Rybelsus;Ozempic;Semaglutide (H-7894.0001) |
| CAS: | 910463-68-2 |
| MF: | C187H291N45O59 |
| MW: | 4113.57754 |
| EINECS: | 203-405-2 |
| Product Categories: | GLP;PP;APIs;API;910463-68-2 |
| Mol File: | 910463-68-2.mol |
Hot Selling Products
| Products name | CAS No. | Products name | CAS No. |
| Tetracai | 94-24-* | Tetra HCL | 136-47-* |
| Lidocain | 137-58-* | Lidocain HCL | 73-78-* |
| Procai | 59-46-* | Procai HCL | 51-05-* |
| Benzocain* | 94-09-* | Tetramisole HCL | 5086-74-8 |
| Paracetamol | 103-90-2 | Levamisole HCL | 16595-80-5 |
| Silde nafil(Via gra) | 139755/83/2 | Varde nafil | 224785/91/55 |
| Xylazi n HCL | 23076-35- 9 | Prilocaine | 721-50-6 |
| Prilocaine HCL | 1786-81-8 | Bupivacaine | 2180-92-9 |
| Bupivacaine HCI | 14252-80-3 | Levobupivacaine HCL | 27262-48-2 |
| Pramoxine HCI | 637-58-1 | Proparacaine HCI | 5875-06-9 |
| Articaine HCI | 23964-57-0 | Mepivacaine HCl | 1722-62-9 |
| Dibucaine HCL | 61-12-1 | Coluracetam | 135463-81-9 |
| Oxiracetam | 62613-82-5 | Diltiazem | 42399-41-7 |
| Tryptamine | 61-54-1 | ||
| Topiramate | 97240-79-4 | Phenibu | 1078-21-* |
| Europiumchloride | 10025-76-0 | BM* | 203 |
Reviews
There are no reviews yet.